VANCOUVER, British Columbia, Canada – Precision NanoSystems, Inc. (PNI), a privately held biotechnology company developing proprietary microfluidic-based manufacturing technology for the use and development of cutting edge nanomedicines, today announced the launch of its product specific websites: http://sub9kits.com/ and Nano Assemblr.
PNI’s proprietary microfluidic-based platform enables the rapid and simple manufacturing of novel nanomedicines for use in medical research and medicine. PNI’s SUB9KITSTM allow medical researchers to use nanomedicines to more rapidly identify genes causing disease including cancers, neurodegeneration diseases, metabolic disorders, and others. The NanoAssemblrTM Platform allows drug developers to more rapidly develop cutting-edge nanomedicines to more effectively treat these diseases. The SUB9KITSTM and NanoAssemblrTM websites are specifically tailored to the needs of medical researchers and drug developers, respectively.
PNI’s CEO, Dr. James Taylor, commented, “The launch of our product websites is a major milestone for PNI and is timed to our upcoming launches of our SUB9KITSTM and NanoAssemblrTM products. PNI’s products are based on our cutting-edge and proprietary platform for nanomedicine manufacturing and are highly enabling to our users. We are excited to get these products to our customers and to accelerate the understanding and treatment of disease. Our websites will be used as a portal for providing information to our customers and act as a conduit for purchasing.”
About Precision NanoSystems, Inc.
At Precision NanoSystems we are creating innovative tools for the development and manufacture of best-in-class nanoparticles for use as medicines, and in medical research. Our proprietary NanoAssemblr platform enables the simple, rapid, reproducible, and scalable manufacture of next-generation nanoparticle formulations for the targeted delivery of therapeutic and diagnostic agents to difficult-to-access cells and tissues in the body. We provide instruments, reagents and services to life sciences researchers and build strategic collaborations to revolutionize healthcare through nanotechnology. To join the revolution visit our website.